Aresa – changing the strategic focus to investments in and development of mine-affected land - still with a humanitarian scope - read the press release

Aresa has been working within plant biotechnology. The company was founded in 2001 by Carsten Meier, who is presently the Chief Scientific Officer. Aresa has its scientific outset from the Institute of Molecular Biology and Physiology, Copenhagen University, that has supported the company since its foundation with consulting, facilities and scientific staff.

By February 2006, Aresa was listed on the First North listing of the Copenhagen Stock Exchange (currently Nasdaq/OMX-group).

Aresa A/S is situated in Symbion Science Park in Copenhagen. This Science Park houses approx. 100 small companies primarily within Biotechnology and IT.

As of January 2008, Aresa has 11 employees.

Aresa has been working on the BioSensor patent protected technology
Since its establishment Aresa has developed plant based technology platforms, and in 2002 we filed two international patent applications. 

The use of the the Company’s BioSensor technology, in the shape of the product candidates RedDetect, RedDetect UXO and RedScreen have been selected to be among the most innovative ideas in the World in 2004, by the New York Times. In 2005, the Company’s Chief Scientific Officer, Carsten Meier was awarded the Annual Innovation Price of the Carl Bro Group (Danish Consultancy Firm) for the efforts in developing the Company’s technology.
For a description af the Mine Action Plant and the technology behind it, please see the Landmine Plant section.